Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 3Small Cell Lung Carcinoma 2Smoking 1Pulmonary Disease, Chronic Obstructive 1Precancerous Conditions 1

Interventions

Tomography, X-Ray Computed 2Tobacco Use Cessation Devices 2Vitamin B 12 1Videotape Recording 1Varenicline 1Standard of Care 1Smoking Devices 1Radon 1Psychiatric Rehabilitation 1Practice Guidelines as Topic 1Phlebotomy 1Patient Navigation 1Nicotine 1Mass Screening 1Folic Acid 1Focus Groups 1Erlotinib Hydrochloride 1Cycloserine 1Bupropion 1Budesonide 1Bronchoscopy 1Blood Specimen Collection 110-propargyl-10-deazaaminopterin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Smoking × Budesonide × Thoracic × Clear all
NCT00321893 2016-01-25

Budesonide in Treating Patients With Lung Nodules at High Risk of Developing Lung Cancer

National Cancer Institute (NCI)

Phase 2 Completed
225 enrolled 10 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Smoking, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡